American International Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,418
| Closed | -$778K | – | 3019 |
|
|
2022
Q4 | $778K | Sell |
23,418
-186
| -0.8% | -$5.99K | 0.01% | 1340 |
|
|
2022
Q3 | $744K | Buy |
23,604
+269
| +1% | +$8.71K | 0.01% | 1344 |
|
|
2022
Q2 | $710K | Sell |
23,335
-1,164
| -5% | -$31.5K | ﹤0.01% | 1397 |
|
|
2022
Q1 | $636K | Sell |
24,499
-1,485
| -6% | -$35.3K | ﹤0.01% | 1590 |
|
|
2021
Q4 | $530K | Sell |
25,984
-836
| -3% | -$16K | ﹤0.01% | 1768 |
|
|
2021
Q3 | $516K | Sell |
26,820
-932
| -3% | -$18.6K | ﹤0.01% | 1834 |
|
|
2021
Q2 | $616 | Sell |
27,752
-510
| -2% | -$10.8K | ﹤0.01% | 1793 |
|
|
2021
Q1 | $742 | Sell |
28,262
-320
| -1% | -$7.61K | ﹤0.01% | 1624 |
|
|
2020
Q4 | $534 | Sell |
28,582
-692
| -2% | -$12.9K | ﹤0.01% | 1708 |
|
|
2020
Q3 | $497K | Sell |
29,274
-720
| -2% | -$14K | ﹤0.01% | 1589 |
|
|
2020
Q2 | $699K | Buy |
29,994
+966
| +3% | +$14K | ﹤0.01% | 1418 |
|
|
2020
Q1 | $244K | Sell |
29,028
-1,441
| -5% | -$12.1K | ﹤0.01% | 1798 |
|
|
2019
Q4 | $298K | Sell |
30,469
-822
| -3% | -$7.72K | ﹤0.01% | 1980 |
|
|
2019
Q3 | $297K | Sell |
31,291
-344
| -1% | -$3.63K | ﹤0.01% | 1943 |
|
|
2019
Q2 | $376K | Buy |
31,635
+131
| +0.4% | +$1.58K | ﹤0.01% | 1859 |
|
|
2019
Q1 | $555K | Sell |
31,504
-843
| -3% | -$14K | ﹤0.01% | 1639 |
|
|
2018
Q4 | $562K | Sell |
32,347
-384
| -1% | -$6.55K | ﹤0.01% | 1598 |
|
|
2018
Q3 | $488K | Buy |
32,731
+623
| +2% | +$9.66K | ﹤0.01% | 1918 |
|
|
2018
Q2 | $511K | Buy |
32,108
+5,482
| +21% | +$81.8K | ﹤0.01% | 1827 |
|
|
2018
Q1 | $378K | Sell |
26,626
-6,556
| -20% | -$97K | ﹤0.01% | 1896 |
|
|
2017
Q4 | $465K | Buy |
33,182
+131
| +0.4% | +$1.92K | ﹤0.01% | 1833 |
|
|
2017
Q3 | $473K | Buy |
33,051
+1,789
| +6% | +$25.6K | ﹤0.01% | 1795 |
|
|
2017
Q2 | $492K | Buy |
31,262
+5,595
| +22% | +$80.6K | ﹤0.01% | 1715 |
|
|
2017
Q1 | $354K | Sell |
25,667
-4,960
| -16% | -$69.4K | ﹤0.01% | 1842 |
|
|
2016
Q4 | $542K | Sell |
30,627
-449
| -1% | -$7.89K | ﹤0.01% | 1584 |
|
|
2016
Q3 | $599K | Sell |
31,076
-21
| -0.1% | -$411 | ﹤0.01% | 1505 |
|
|
2016
Q2 | $606K | Sell |
31,097
-425
| -1% | -$8.34K | ﹤0.01% | 1475 |
|
|
2016
Q1 | $650K | Buy |
31,522
+1,469
| +5% | +$28.9K | ﹤0.01% | 1805 |
|
|
2015
Q4 | $617K | Buy |
30,053
+341
| +1% | +$6.54K | ﹤0.01% | 1867 |
|
|
2015
Q3 | $508K | Buy |
29,712
+179
| +0.6% | +$3.27K | ﹤0.01% | 2005 |
|
|
2015
Q2 | $550K | Sell |
29,533
-1,665
| -5% | -$30.9K | ﹤0.01% | 2091 |
|
|
2015
Q1 | $595K | Sell |
31,198
-484
| -2% | -$8.95K | ﹤0.01% | 2014 |
|
|
2014
Q4 | $521K | Sell |
31,682
-1,924
| -6% | -$33K | ﹤0.01% | 2100 |
|
|
2014
Q3 | $594K | Buy |
33,606
+177
| +0.5% | +$3.48K | ﹤0.01% | 1969 |
|
|
2014
Q2 | $690K | Sell |
33,429
-668
| -2% | -$13.7K | ﹤0.01% | 1895 |
|
|
2014
Q1 | $743K | Buy |
34,097
+873
| +3% | +$20K | ﹤0.01% | 1783 |
|
|
2013
Q4 | $881K | Buy |
33,224
+175
| +0.5% | +$4.3K | ﹤0.01% | 1564 |
|
|
2013
Q3 | $782K | Sell |
33,049
-2,117
| -6% | -$49.4K | ﹤0.01% | 1607 |
|
|
2013
Q2 | $756K | Buy |
+35,166
| New | +$758K | ﹤0.01% | 1556 |
|
Other funds holding VIVO
American International Group's VIVO Position: Q1 2023 in Review
American International Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 23,418 shares — an estimated $778K sold.
American International Group first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $881K in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- American International Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- American International Group sold 23,418 Meridian Bioscience Inc shares in Q1 2023, an estimated $778K.
- American International Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
- American International Group's Meridian Bioscience Inc position peaked at $881K in Q4 2013.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on American International Group's 13F filing for Q1 2023, filed 12 May 2023.